| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 32,333 | 32,457 | 34,321 | 35,720 | | Cost of Revenue | (31,034) | 32,681 | 37,055 | 31,455 | | | Gross Profit | 63,367 | (224) | (2,734) | 4,265 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 63,262 | 520 | 4,683 | 5,023 | | Non Recurring | 1,087 | 666 | 50,667 | (83) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (982) | (1,410) | (58,084) | (675) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,591) | (1,410) | (58,084) | (675) | | Interest Expense | (202) | 202 | 234 | 222 | | Income Before Tax | (1,389) | (1,612) | (58,318) | (897) | | Income Tax Expense | (404) | (556) | (11,986) | (797) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (985) | (1,056) | (46,332) | (100) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (985) | (1,056) | (46,332) | (100) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($985) | ($1,056) | ($46,332) | ($100) |
|
0.26% Nasdaq 0.00%
Income Statement
